Skip Navigation

European Heart Journal 2000 21(19):1572-1573; doi:10.1053/euhj.2000.2387
Copyright © 2000 by the European Society of Cardiology.
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Fruchart, J.C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fruchart, J.C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Editorial

A need to redefine the consensus on the use of statins in coronary heart disease prevention

J.C. Fruchart

Department of Atherosclerosis, Institut Pasteur de Lille, Lille, France

References

  1. Vaughan CJ, Gotto AM Jr, Basson CT. The evolving role of statins in the management of atherosclerosis. J Am Coll Cardiol. 2000;35:1–10[Abstract/Free Full Text]
  2. Shepherd J, Cobbe SM, Ford I. Prevention of coronary heart disease with Pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med. 1995;333:1301–1307[Abstract/Free Full Text]
  3. Downs JR, Clearfield M, Weis S. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA. 1998;279:1615–1622[Abstract/Free Full Text]
  4. Gotto AM Jr, Whitney E, Stein EA. Application of the National Cholesterol Education Program and joint European treatment criteria and clinical benefit in the Air Force/Texas Coronary Atherosclerosis prevention Study (AFCAPS/TexCAPS). Eur Heart J. 2000;21:1627–1633[Abstract/Free Full Text]
  5. JAMA. 1993;269:3015–3023[Abstract/Free Full Text]
  6. Assmann G, Carmena R, Cullen P. Coronary heart disease: reducing the risk: a worldwide view. International Task Force for the Prevention of Coronary Heart Disease. Circulation. 1999;100:1930–1938[Free Full Text]
  7. Assmann G, Cullen P, Fruchart C, Lewis B, Mancini M, Carmena R. Coronary Heart Disease Prevention Task Force. Eur Heart J. 1999;20:841–844[Free Full Text]
  8. Farmer JA. Pleiotropic effects of statins. Curr Atheroscler Rep. 2000;2:208–217[Medline]
  9. Rogers MJ. Statins: Lower lipid and better bones? Nature Med. 2000;6:21–23
  10. Davignon J, Laaksonen R. Low-density lipoprotein-independent effects of statins 1. Curr Opin Lipidol. 1999;10:543–559[CrossRef][Web of Science][Medline]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Fruchart, J.C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fruchart, J.C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?